|
gptkb:J02AA01
|
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
|
gptkb:Diseases_of_the_Urinary_Organs
|
ICD-10 N00-N39
|
|
gptkb:A02BA01
|
Antacids, aluminium compounds
|
|
gptkb:J05AX12
|
other antivirals
|
|
gptkb:Folic_Podzol
|
Canadian System of Soil Classification
|
|
gptkb:L02BA03
|
L02BA Anti-estrogens
|
|
gptkb:L01AD02
|
L01A Alkylating agents
|
|
gptkb:L02BA03
|
L Antineoplastic and immunomodulating agents
|
|
gptkb:G04BD09
|
Genito urinary system and sex hormones
|
|
gptkb:V03AE07
|
all other therapeutic products
|
|
gptkb:rhodopsin-like_2
|
gptkb:Class_A_GPCRs
|
|
gptkb:J06BB06
|
immune sera and immunoglobulins
|
|
gptkb:L02BA03
|
L02B Hormone antagonists and related agents
|
|
gptkb:L01XE29
|
antineoplastic agents
|
|
gptkb:L02BA03
|
L02 Endocrine therapy
|
|
gptkb:Malignant_neoplasm_of_other_endocrine_glands_and_related_structures
|
neoplasms of endocrine glands
|
|
gptkb:A08AX01
|
Alimentary tract and metabolism
|
|
gptkb:N03AB02
|
benzodiazepine derivatives
|